NCT00370253View on ClinicalTrials.gov

Noradrenalin vs Terlipressin in Hepatorenal Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Hepatorenal Syndrome
Interventions
DRUG

Terlipressin

1mg/4 h per day

DRUG

Noradrenalin

0,1 mcg/kg/min

Trial Locations (1)

10126

San Giovanni Battista Hospital, Turin

All Listed Sponsors
lead

University of Turin, Italy

OTHER

NCT00370253 - Noradrenalin vs Terlipressin in Hepatorenal Syndrome | Biotech Hunter | Biotech Hunter